ERBB2 and head and neck squamous cell carcinoma: The human epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, including EGFR, Her2, and Her3, is a potent target for antitumor strategies as it plays a critical role in HNSCC tumor cell growth, survival, invasion, metastasis and angiogenesis.